These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 25061277)
41. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Bisgaard H; Zielen S; Garcia-Garcia ML; Johnston SL; Gilles L; Menten J; Tozzi CA; Polos P Am J Respir Crit Care Med; 2005 Feb; 171(4):315-22. PubMed ID: 15542792 [TBL] [Abstract][Full Text] [Related]
42. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma. Kubavat AH; Khippal N; Tak S; Rijhwani P; Bhargava S; Patel T; Shah N; Kshatriya RR; Mittal R Am J Ther; 2013; 20(2):154-62. PubMed ID: 22926233 [TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis. Virchow JC; Bachert C Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955 [TBL] [Abstract][Full Text] [Related]
44. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group. Altman LC; Munk Z; Seltzer J; Noonan N; Shingo S; Zhang J; Reiss TF J Allergy Clin Immunol; 1998 Jul; 102(1):50-6. PubMed ID: 9679847 [TBL] [Abstract][Full Text] [Related]
45. Effects of exercise training and montelukast in children with mild asthma. Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200 [TBL] [Abstract][Full Text] [Related]
46. Montelukast as an alternative to low-dose inhaled corticosteroids in the management of mild asthma (the SIMPLE trial): an open-label effectiveness trial. McIvor RA; Kaplan A; Koch C; Sampalis JS Can Respir J; 2009; 16 Suppl A(Suppl A):11A-21A. PubMed ID: 19557207 [TBL] [Abstract][Full Text] [Related]
47. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616 [TBL] [Abstract][Full Text] [Related]
48. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400 [TBL] [Abstract][Full Text] [Related]
49. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study. Ilowite J; Webb R; Friedman B; Kerwin E; Bird SR; Hustad CM; Edelman JM Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766 [TBL] [Abstract][Full Text] [Related]
50. [What is the role of montelukast in asthma treatment?]. Aksu K; Aksu F Tuberk Toraks; 2020 Sep; 68(3):328-330. PubMed ID: 33295731 [TBL] [Abstract][Full Text] [Related]
51. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Vaquerizo MJ; Casan P; Castillo J; Perpiña M; Sanchis J; Sobradillo V; Valencia A; Verea H; Viejo JL; Villasante C; Gonzalez-Esteban J; Picado C; Thorax; 2003 Mar; 58(3):204-10. PubMed ID: 12612294 [TBL] [Abstract][Full Text] [Related]
52. Risk factors for montelukast treatment failure in step-down therapy for controlled asthma. Drummond MB; Peters SP; Castro M; Holbrook JT; Irvin CG; Smith LJ; Wise RA; Sugar EA; J Asthma; 2011 Dec; 48(10):1051-7. PubMed ID: 22029858 [TBL] [Abstract][Full Text] [Related]
53. Should we use montelukast in wheezy children? Haq I; Harris C; Taylor J; McKean MC; Brodlie M Arch Dis Child; 2017 Nov; 102(11):997-998. PubMed ID: 28780506 [No Abstract] [Full Text] [Related]
54. Role of Montelukast in treatment of mild and severe forms of asthma. Ekaladze E; Pkhakadze I; Alavidze N; Jugeli K Georgian Med News; 2014; (232-233):56-60. PubMed ID: 25214273 [TBL] [Abstract][Full Text] [Related]
55. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients. Tohda Y; Fujimura M; Taniguchi H; Takagi K; Igarashi T; Yasuhara H; Takahashi K; Nakajima S Clin Exp Allergy; 2002 Aug; 32(8):1180-6. PubMed ID: 12190656 [TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma. Meltzer EO; Lockey RF; Friedman BF; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K; Mayo Clin Proc; 2002 May; 77(5):437-45. PubMed ID: 12004993 [TBL] [Abstract][Full Text] [Related]
57. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS; J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681 [TBL] [Abstract][Full Text] [Related]
58. Montelukast: more than a cysteinyl leukotriene receptor antagonist? Tintinger GR; Feldman C; Theron AJ; Anderson R ScientificWorldJournal; 2010 Dec; 10():2403-13. PubMed ID: 21170491 [TBL] [Abstract][Full Text] [Related]
59. Effect of addition of single dose of oral montelukast to standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age: a randomised, double-blind, placebo controlled trial. Todi VK; Lodha R; Kabra SK Arch Dis Child; 2010 Jul; 95(7):540-3. PubMed ID: 20522464 [TBL] [Abstract][Full Text] [Related]
60. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors. Ducharme FM; Noya FJ; Allen-Ramey FC; Maiese EM; Gingras J; Blais L Curr Med Res Opin; 2012 Jan; 28(1):111-9. PubMed ID: 22077107 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]